Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Endocrine ophthalmopathy
ADR ID BADD_A09856
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.08      Endocrine autoimmune disorders
10.04.08.012      Endocrine ophthalmopathy
06      Eye disorders
06.09      Ocular structural change, deposit and degeneration NEC
06.09.04      Structural change, deposit and degeneration of eye NEC
06.09.04.008      Endocrine ophthalmopathy
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC
14.11.01.051      Endocrine ophthalmopathy
05      Endocrine disorders
05.02      Thyroid gland disorders
05.02.02      Thyroid hyperfunction disorders
05.02.02.008      Endocrine ophthalmopathy
Description Not Available
MedDRA Code 10060742
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Endocrine exophthalmos | Exophthalmic thyrotoxicosis | Exophthalmos endocrine | Exophthalmos thyrotoxic | Thyrotoxic exophthalmos | Graves' ophthalmopathy | Endocrine ophthalmopathy | Graves' ophthalmopathy worsened | Thyroid associated orbitopathy | Thyroid eye disease
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.000241%
BADD_D00788Epoprostenol0.000082%
BADD_D01567Nilotinib0.000112%
BADD_D01933Ribavirin0.005934%
BADD_D02105Tacrolimus--
The 1th Page    1    Total 1 Pages